MEDICLINIC INTERNATIONAL PLC - Total voting rights

Total voting rights

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88

TOTAL VOTING RIGHTS

In accordance with Disclosure and Transparency Rule 5.6.1R, as at 29 February 2016, the
issued share capital and voting rights of Mediclinic International plc were as follows:


Class of shares in issue                                          Ordinary shares of 10p each
Number of ordinary shares in issue                                                737,243,810
Number of shares held in Treasury                                                           0
Total nominal value of issued shares                                           GBP 73,724,381
Total Voting Rights                                                               737,243,810

The above total voting rights figure (737,243,810) may be used by shareholders as the
denominator for the calculations by which they will determine whether they are required to
notify their interests in, or a change to their interest in Mediclinic International plc under the
FCA's Disclosure and Transparency Rules.

For the purpose of the Transparency Directive the Home Member State of the issuer is the
United Kingdom.

For and on behalf of Mediclinic International plc

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Limited

For further information, please contact:
Company Secretary - Capita Company Secretarial Services Limited
Victoria Dalby      +44 (0)207 954 9528

1 March 2016
Date: 01/03/2016 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.